In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …

Direct oral anticoagulants (DOAC) are currently the drug of choice for drug prevention of
stroke or systemic embolism in patients with atrial fibrillation (AF). However, repeated …

Abstract Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses
without the need for routine laboratory monitoring. Anti-Xa assays can estimate …

The article discusses research which investigated how direct oral anticoagulants (DOAC)
plasma level thresholds may impact thrombin generation assay (TGA) results being used for …

Atrial fibrillation (AF) is a common cardiac arrhythmia that poses a significant risk of stroke
and thromboembolic events. Anticoagulation therapy is essential for preventing stroke in …

Purpose Thromboembolic or hemorrhagic complications related to atrial fibrillation (AF)
ablation are rare, and thus, it is difficult to compare their frequency across different direct oral …

Most patients present for catheter ablation of atrial fibrillation (CAAF) with residual or full
effect of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs). In daily …

Рассмотрены современные подходы к использованию лабораторных методов для
усовершенствования тактики применения прямых пероральных антикоагулянтов …

Background Atrial fibrillation (AF) ablation with minimally interrupted direct oral
anticoagulants (DOACs) may raise a concern about their remaining activity. We tested the …